SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1935)10/4/2007 11:52:38 AM
From: Jibacoa  Respond to of 3722
 
After its recent double bottom at the 1.36 level, VXGN is moving up with the help of filing its 10Q,which may bring it compliance with the requirements of the SEC.The stock has been up more than 15% today.<g>

bigcharts.marketwatch.com

Will see if VXGN can regain a listing on the NAZ & the stock can get above the $1.60 level.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1935)10/6/2007 10:10:21 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
As I mentioned, the R/R wasn't bad on NEOL at that level.<g>

The stock yesterday was able to go through the resistance at 1.20 & was able to trade at the 1.64 level at 10:30AM

The stock was up 20.58% during the regular sesion & was up another 7.5% AHs.

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News